Avid Bioservices, Inc. Annual Deferred Income Tax Expense (Benefit) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Avid Bioservices, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from 2019 to 2023.
  • Avid Bioservices, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending July 31, 2024 was $0.000.
  • Avid Bioservices, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was $114M, a 8452% increase from 2022.
  • Avid Bioservices, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was $1.33M.
  • Avid Bioservices, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was -$115M.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $114M +$112M +8452% May 1, 2023 Apr 30, 2024 10-K 2024-07-02
2022 $1.33M +$116M May 1, 2022 Apr 30, 2023 10-K 2024-07-02
2021 -$115M -$115M May 1, 2021 Apr 30, 2022 10-K 2024-07-02
2020 $0 $0 May 1, 2020 Apr 30, 2021 10-K/A 2024-04-24
2019 $0 May 1, 2019 Apr 30, 2020 10-K 2022-06-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.